Neurospecific Proteins as Transdiagnostic Markers of Affective Disorders
- Authors: Levchuk L.A.1, Bokhan N.A.1, Ivanova S.A.1
-
Affiliations:
- Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
- Issue: Vol 40, No 1 (2023)
- Pages: 30-34
- Section: Review Articles
- URL: https://vietnamjournal.ru/1027-8133/article/view/653954
- DOI: https://doi.org/10.31857/S1027813323010119
- EDN: https://elibrary.ru/EPHTPP
- ID: 653954
Cite item
Abstract
Mental disorders have many differences in pathogenesis and clinical symptoms, however, they are characterized by general neurobiological processes that occur with a damage of nervous tissue, disturbance of blood-brain barrier, inclusion of autoimmune mechanisms, neurodegenerative processes and release of neurospecific proteins into the liquor and into the blood. We presented a review of current literature devoted to studies of the role of neurospecific proteins in the pathogenesis of affective disorders. Glial fibrillar acidic protein (GFAP), S-100 protein, myelin basic protein (MBP), and neuron specific enolase (NSE) reflect damage of neurons, astrocytes and oligodendrocytes in depressive disorders and they could be considered as transdiagnostic nonspecific markers of affective disorders.
About the authors
L. A. Levchuk
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: nchjournal@gmail.com
Russia, Tomsk
N. A. Bokhan
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: nchjournal@gmail.com
Russia, Tomsk
S. A. Ivanova
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: nchjournal@gmail.com
Russia, Tomsk
References
- Maiolo L., Guarino V., Saracino E., Convertino A., Melucci M., Muccini M., Ambrosio L., Zamboni R., Benfenati V. // Adv. Healthc. Mater. 2021. V. 10. № 1. e2001268. https://doi.org/10.1002/adhm.202001268
- Mayegowda S.B., Thomas C. // J. Basic Clin. Physiol. Pharmacol. 2019. V. 30. № 4. https://doi.org/10.1515/jbcpp-2018-0120
- Franke H., Illes P. // Neurosci. Lett. 2014. V. 565. P. 14–22. https://doi.org/10.1016/j.neulet.2013.09.056
- Kaul D., Schwab S.G., Mechawar N., Matosin N. // Neurosci. Biobehav. Rev. 2021. V. 124. P. 193–215. https://doi.org/10.1016/j.neubiorev.2021.01.025
- Keshavarz M. // Acta Neuropsychiatr. 2017. V. 29. № 3. P. 140–152. https://doi.org/10.1017/neu.2016.56
- Rajkowska G., Miguel-Hidalgo J.J. // Methods Mol. Biol. 2019. V. 1938. P. 247–254. https://doi.org/10.1007/978-1-4939-9068-9_17
- Wang J., Qin J., Wang P., Sun Y., Zhang Q. // Mediators Inflamm. 2020. V. 2020, Article ID 3497920. https://doi.org/10.1155/2020/3497920
- Gules E., Iosifescu D.V., Tural U. // Neuropsychobiology. 2020. V. 79. № 3. P. 214–221. https://doi.org/10.1159/000505782
- Karabulut S., Taşdemir I., Akcan U., Kucukali C.I., Tuzun E., Çakır S. // Turk. Psikiyatri Derg. 2019. V. 30. № 2. P. 75–81.
- Block M.L., Hong J.S. // Prog. Neurobiol. 2005. V. 76. № 2. P.77–98. https://doi.org/10.1016/j.pneurobio.2005.06.004
- Zavorotnyy M., Zollner R., Schulte-Gustenberg L.R., Wulff L., Schoning S., Dannlowski U., Kugel H., Arolt V., Konrad C. // J. Neural. Transm. (Vienna). 2018. V. 125. № 2. P. 229–238. https://doi.org/10.1007/s00702-017-1811-y
- Lotrich F.E., Butters M.A., Aizenstein H., Marron M.M., Reynolds C.F. 3rd, Gildengers A.G. // Int. J. Geriatr. Psychiatry. 2014. V. 29. № 6. P. 635–44. https://doi.org/10.1002/gps.4048
- Losenkov I.S., Mulder N.J.V., Levchuk L.A., Vyalova N.M., Loonen A.J.M., Bosker F.J., Simutkin G.G., Boiko A.S., Bokhan N.A., Wilffert B., Hak E., Schmidt A.F., Ivanova S.A. // Front. Psychiatry. 2020. V. 11. P. 38. https://doi.org/10.3389/fpsyt.2020.00038
- Erickson E.K., Grantham E.K., Warden A.S., Harris R.A. // Pharmacol. Biochem. Behav. 2019. V. 177. P. 34–60. https://doi.org/10.1016/j.pbb.2018.12.007
- Kruyer A., Kalivas P.W., Scofield M.D. // Neuropsychopharmacology. 2022. Epub ahead of printhttps://doi.org/10.1038/s41386-022-01338-w
- Wang Q., Jie W., Liu J.H., Yang J.M., Gao T.M. // Glia. 2017. V. 65. № 8. P. 1227–1250. https://doi.org/10.1002/glia.23143
- Schroeter M.L., Sacher J., Steiner J., Schoenknecht P., Mueller K. // Curr. Drug Targets. 2013. V. 14. № 11. P. 1237–1248. https://doi.org/10.2174/13894501113149990014
- Giovannoni F., Quintana F.J. // Trends Immunol. 2020. V. 41. № 9. P. 805–819. https://doi.org/10.1016/j.it.2020.07.007
- Gulyaeva N.V. // J. Neurochem. 2015. V. 132. № 3. P. 263–265. https://doi.org/10.1111/jnc.13016
- Sofroniew M.V. // Trends Immunol. 2020. V. 41. № 9. P. 758–770. https://doi.org/10.1016/j.it.2020.07.004
- Miguel-Hidalgo J.J., Waltzer R., Whittom A.A., Austin M.C., Rajkowska G., Stockmeier C.A. // J. Affect. Disord. 2010. V. 127. Issue 1–3. P. 230–240. https://doi.org/10.1016/j.jad.2010.06.003
- Kim R., Healey K.L., Sepulveda-Orengo M.T., Reissner K.J. // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2018. V. 87. Pt A. P. 126–146. https://doi.org/10.1016/j.pnpbp.2017.10.002
- Qi X.R., Kamphuis W., Shan L. // Front. Cell Neurosci. 2019. V. 13. P. 503. https://doi.org/10.3389/fncel.2019.00503
- Steinacker P., Al Shweiki M.R., Oeckl P., Graf H., Ludolph A.C., Schonfeldt-Lecuona C., Otto M. // J. Psychiatr. Res. 2021. V. 144. P. 54–58. https://doi.org/10.1016/j.jpsychires.2021.09.012
- Donato R., Cannon B.R., Sorci G., Riuzzi F., Hsu K., Weber D.J., Geczy C.L. // Curr. Mol. Med. 2013. V. 13. № 1. P. 24–57.
- Baecker J., Wartchow K., Sehm T., Ghoochani A., Buchfelder M., Kleindienst A. // J. Neurotrauma. 2020. V. 37. № 8. P. 1097–1107. https://doi.org/10.1089/neu.2019.6475
- Bartoli F., Misiak B., Crocamo C., Carra G. // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2020. V. 101. P. 109922. https://doi.org/10.1016/j.pnpbp.2020.109922
- Ceschi M.A., da Costa J.S., Lopes J., Câmara V.S., Campo L.F., Borges A., Goncalves C., de Souza D.F., Konrath E.L., Karl A., Guedes I.A., Dardenne L.E. // Eur. J. Med. Chem. 2016. V. 121. P. 758–772. https://doi.org/10.1016/j.ejmech.2016.06.025
- Michetti F., D’Ambrosi N., Toesca A., Puglisi M.A., Serrano A., Marchese E., Corvino V., Geloso M.C. // J. Neurochem. 2019. V. 148. № 2. P. 168–187. https://doi.org/10.1111/jnc.14574
- Zhang L., Verwer R.W.H., Zhao J., Huitinga I., Lucassen P.J., Swaab D.F. // J. Affect. Disord. 2021. V. 295. P. 893–903. https://doi.org/10.1016/j.jad.2021.08.098
- Kroksmark H., Vinberg M. // Nord. J. Psychiatry. 2018. V. 72. № 7. P. 462–470. https://doi.org/10.1080/08039488.2018.1472295
- Tural U., Irvin M.K., Iosifescu D.V. // World J. Biol. Psychiatry. 2021. V. 15. P. 1–8. https://doi.org/10.1080/15622975.2021.2013042
- Navines R., Oriolo G., Horrillo I., Cavero M., Aouizerate B., Schaefer M., Capuron L., Meana J.J., Martin-Santos R. // Int. J. Neuropsychopharmacol. 2022. V. 25. № 6. P. 468–478. https://doi.org/10.1093/ijnp/pyac016
- Andreazza A.C., Cassini C., Rosa A.R., Leite M.C., de Almeida L.M., Nardin P., Cunha A.B., Cereser K.M., Santin A., Gottfried C., Salvador M., Kapczinski F., Goncalves C.A. // J. Psychiatr. Res. 2007. V. 41. № 6. P. 523–529. https://doi.org/10.1016/j.jpsychires.2006.07.013
- Machado-Vieira R., Lara D.R., Portela L.V., Goncalves C.A., Soares J.C., Kapczinski F., Souza D.O. // Eur. Neuropsychopharmacol. 2002. V. 12. № 3. P. 269–272. https://doi.org/10.1016/s0924-977x(02)00029-9
- Salzer J.L., Zalc B. // Curr. Biol. 2016. V. 26. № 20. R971–R975. https://doi.org/10.1016/j.cub.2016.07.074
- Harauz G., Ladizhansky V., Boggs J.M. // Biochemistry. 2009. V. 48. № 34. P. 8094–104. https://doi.org/10.1021/bi901005f
- English J.A., Pennington K., Dunn M.J., Cotter D.R. // Biol. Psychiatry. 2011. V. 69. № 2. P. 163–172. https://doi.org/10.1016/j.biopsych.2010.06.031
- Williams M.R., Sharma P., Macdonald C., Pearce R.K.B., Hirsch S.R., Maier M. // Eur. Arch. Psychiatry. Clin. Neurosci. 2019. V. 269. № 4. P. 387–395. https://doi.org/10.1007/s00406-018-0904-4
- Valdes-Tovar M., Rodriguez-Ramirez A.M., Rodriguez-Cardenas L., Sotelo-Ramirez C.E., Camarena B., Sanabrais-Jimenez M.A., Solis-Chagoyan H., Argueta J., Lopez-Riquelme G.O. // World J. Psychiatry. 2022. V. 12. № 2. P. 264–285. https://doi.org/10.5498/wjp.v12.i2.264
- Schmitt A., Simons M., Cantuti-Castelvetri L., Falkai P. // Eur. Arch. Psychiatry Clin. Neurosci. 2019. V. 269. № 4. P. 371–372. https://doi.org/10.1007/s00406-019-01019-8
- Jakobsson J., Bjerke M., Ekman C.J., Sellgren C., Johansson A.G., Zetterberg H., Blennow K., Landen M. // Neuropsychopharmacology. 2014. V. 39. № 10. P. 2349–2356. https://doi.org/10.1038/npp.2014.81
- Levchuk L.A., Roshchina O.V., Simutkin G.G., Bokhan N.A., Ivanova S.A. // Neurochemical Journal. 2021. V. 15. № 1. P. 86–90. https://doi.org/10.1134/S1819712421010074
- Schmidt F.M., Mergl R., Stach B., Jahn I., Schonknecht P. // World J. Biol. Psychiatry. 2015. V. 16. P. 106–113. https://doi.org/10.3109/15622975.2014.952776
- Isgro M.A., Bottoni P., Scatena R. // Adv. Exp. Med. Biol. 2015. V. 867. P. 125–143. https://doi.org/10.1007/978-94-017-7215-0_9
- Streitburger D.P., Arelin K., Kratzsch J., Thiery J., Steiner J., Villringer A., Mueller K., Schroeter M.L. // PLoS One. 2012. V. 7. № 8. e43284. https://doi.org/10.1371/journal.pone.0043284
- Shi X.F., Kondo D.G., Sung Y.H., Hellem T.L., Fiedler K.K., Jeong E.K., Huber R.S., Renshaw P.F. // Bipolar Disord. 2012. V. 14. № 6. P. 607–617. https://doi.org/10.1111/j.1399-5618.2012.01040.x
- Eyre H., Baune B.T. // Psychoneuroendocrinology. 2012. V. 37. № 9. P. 1397–1416. https://doi.org/10.1016/j.psyneuen.2012.03.019
Supplementary files
